At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 12 enrolled
Drug / intervention
PF-07038124 or vehicle +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A PHASE 1, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL COHORT STUDY TO EVALUATE THE SAFETY, TOLERABILITY, SKIN IRRITATION POTENTIAL AND PHARMACOKINETICS OF MULTIPLE-DOSE, TOPICAL ADMINISTRATION OF PF-07038124 TO JAPANESE HEALTHY PARTICIPANTS
In Brief
A Phase 1 clinical trial evaluating PF-07038124 or vehicle for Healthy. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety, tolerability, skin irritation potential, and PK of PF-07038124 in Japanese healthy adult participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesJapan
Collaborators--
Timeline
Phase 1CompletedFinished
20222023202420252026
First PostedApr 2021
Enrollment StartJun 2021
Primary CompletionSep 2021
TodayJul 2026
First PostedApr 28, 2021
Enrollment StartJun 30, 2021
Primary CompletionSep 9, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.2 years ago
Interventions
PF-07038124 or vehicledrug
PF-07038124 0.01% or vehicle Ointment QD applied to 2000 cm2 Body Surface Area
PF-07038124 or vehicledrug
PF-07038124 0.01% or vehicle Ointment QD applied to 4000 cm2 Body Surface Area